Skip to content
Business
Prognosis

Moderna Gives WHO’s mRNA Hub Some Help, Pfizer Snubs Request

  • Moderna provides vaccine for comparative studies in mice
  • WHO center is trying to develop its own Covid-19 vaccine
The Moderna vaccine.

The Moderna vaccine.

Photographer: Michaela Handrek-Rehle/Bloomberg
Updated on

Moderna Inc. has allowed its Covid-19 vaccine to be used in a World Health Organization effort to develop mRNA shots that would increase production and access for poor countries.

Afrigen Biologics & Vaccines, a South African biotechnology company working with the WHO, has used the Moderna vaccine in comparison studies in mice to test the effectiveness of its own shots, said Petro Terblanche, Afrigen’s managing director.